z-logo
open-access-imgOpen Access
MP41-15 PROTON PUMP INHIBITOR USE IS A NEGATIVE PROGNOSTIC FACTOR FOR METASTATIC UROTHELIAL CARCINOMA PROGRESSION IN PEMBROLIZUMAB-TREATED PATIENTS
Author(s) -
Kei Iida,
Takashi Nagai,
Satoshi Nozaki,
Toshiki Etani,
Taku Naiki,
Akihiro Nakane,
Hidetoshi Akita,
Hirokazu Kubota,
Hiroyuki Kamiya,
Noriyasu Kawai,
Takahiro Yasui
Publication year - 2021
Publication title -
the journal of urology/the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1097/ju.0000000000002062.15
Subject(s) - medicine , pembrolizumab , oncology , metastatic urothelial carcinoma , cancer , gynecology , immunotherapy , urothelial carcinoma , bladder cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here